SMS Lifesciences India Limited Cash Flow-to-Debt Ratio
SMS Lifesciences India Limited cash flow-to-debt ratio. SMS Lifesciences India Limited (SMSLIFE) has a Cash Flow-to-Debt Ratio of 0.19x as of March 2025, meaning its operating cash flow of Rs340.55 Million could theoretically repay 0% of its total liabilities (Rs1.78 Billion) in one year. Check SMS Lifesciences India Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SMS Lifesciences India Limited (2016–2025)
Cash flow-to-debt ratio of SMS Lifesciences India Limited from 2016 to 2025. Historical debt coverage capacity for SMS Lifesciences India Limited across 10 annual periods. Check SMSLIFE cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
SMS Lifesciences India Limited Cash Flow-to-Debt Ratio by Year (2016–2025)
SMS Lifesciences India Limited cash flow-to-debt ratio by year from 2016 to 2025. Year-by-year debt coverage analysis for SMS Lifesciences India Limited. For the full cash flow conversion analysis, see SMS Lifesciences India Limited (SMSLIFE) cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.17x | Rs298.10 Million | Rs1.78 Billion | ▲ +35.7% |
| 2024 | 0.12x | Rs243.06 Million | Rs1.97 Billion | ▲ +14563879.8% |
| 2023 | 0.00x | Rs1.47K | Rs1.73 Billion | ▲ +100.0% |
| 2022 | -0.06x | Rs-112.41 Million | Rs1.92 Billion | ▼ -128.8% |
| 2021 | 0.20x | Rs351.70 Million | Rs1.73 Billion | ▲ +91.5% |
| 2020 | 0.11x | Rs145.47 Million | Rs1.37 Billion | ▼ -42.1% |
| 2019 | 0.18x | Rs299.93 Million | Rs1.64 Billion | ▲ +102.2% |
| 2018 | 0.09x | Rs80.00 Million | Rs882.47 Million | ▼ -57.0% |
| 2017 | 0.21x | Rs202.60 Million | Rs959.82 Million | ▲ +10.8% |
| 2016 | 0.19x | Rs196.59 Million | Rs1.03 Billion | — |